{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:22:45Z","timestamp":1793067765038,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ygyno.2021.08.023","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:38:09Z","timestamp":1631075889000},"page":"378-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013\u20132019"],"prefix":"10.1016","volume":"163","author":[{"given":"Jin","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Shahangian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.08.023_bb0005","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"Cervical cytology screening","volume":"114","author":"ACOG Practice Bulletin No 109","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.08.023_bb0010","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice bulletin number 131: screening for cervical cancer","volume":"120","author":"Committee on Practice","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.08.023_bb0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"U. S. preventive services task force. Screening for cervical cancer: U.S. preventive services task force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.023_bb0020","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.08.023_bb0030","first-page":"923","article-title":"Practice Bulletin No. 168 summary: cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.08.023_bb0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ygyno.2021.08.023_bb0040","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.023_bb0045","first-page":"1","article-title":"Accuracy of self-reports of pap and mammography screening compared to medical record: a meta-analysis","volume":"20","author":"Howard","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2021.08.023_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/IJWH.S39556","article-title":"Does social disadvantage affect the validity of self-report for cervical cancer screening?","volume":"5","author":"Lofters","year":"2013","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.ygyno.2021.08.023_bb0060","series-title":"Behavioral Risk Factor Surveillance System Survey Data","author":"Centers for Disease Control and Prevention (CDC)","year":"2018"},{"issue":"8","key":"10.1016\/j.ygyno.2021.08.023_bb0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical Cancer screening in 5 states, 2008-2015","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/jwh.2018.7380","article-title":"Trends over time in pap and pap-HPV Cotesting for cervical Cancer screening","volume":"28","author":"MacLaughlin","year":"2019","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.023_bb0075","first-page":"43","article-title":"Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and pap\/HPV cotesting in women aged 30-65 years","volume":"29","author":"Silver","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1309\/AJCPPVX91HQMNYZZ","article-title":"Practice patterns in cervical cancer screening and human papillomavirus testing","volume":"138","author":"Tatsas","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2021.08.023_bb0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0b013e3182253c33","article-title":"Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory","volume":"118","author":"Phelan","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0100","author":"Office of Management and Budget"},{"key":"10.1016\/j.ygyno.2021.08.023_bb0105","author":"ACOG"},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2019.5727","article-title":"Prevalence of potentially unnecessary bimanual pelvic examinations and Papanicolaou tests among adolescent girls and young women aged 15-20 years in the United States","volume":"180","author":"Qin","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","article-title":"National assessment of HPV and pap tests: changes in cervical cancer screening, National Health Interview Survey","volume":"100","author":"Watson","year":"2017","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pmedr.2018.01.010","article-title":"Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014","volume":"9","author":"Watson","year":"2018","journal-title":"Prev. Med. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.023_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-20-0846","article-title":"Assessing impact of HPV vaccination on cervical Cancer incidence among women aged 15-29 years in the United States, 1999-2017: an ecologic study","volume":"30","author":"Mix","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.ygyno.2021.08.023_bb0130","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1097\/01.AOG.0000513946.30609.dc","article-title":"Adherence to recommended cervical cancer screening based on human papillomavirus vaccination status","volume":"129","author":"Terk","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.pmedr.2015.07.011","article-title":"Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population","volume":"2","author":"Paynter","year":"2015","journal-title":"Prev. Med. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.006","article-title":"Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system","volume":"216","author":"Chao","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canep.2016.04.003","article-title":"Associations between prior HPV4 vaccine doses and cervical cancer screening participation","volume":"42","author":"Boone","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0150","first-page":"146(4)","article-title":"Trends in human papillomavirus vaccination in commercially insured children in the United States","author":"Chen","year":"2020","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ygyno.2021.08.023_bb0155","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamainternmed.2019.0298","article-title":"Screening options for preventing cervical Cancer","volume":"179","author":"Feldman","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ypmed.2017.12.007","article-title":"Primary HPV testing: U.S. women\u2019s awareness and acceptance of an emerging screening modality","volume":"108","author":"Saraiya","year":"2018","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000000638","article-title":"Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0170","doi-asserted-by":"crossref","first-page":"105928","DOI":"10.1016\/j.ypmed.2019.105928","article-title":"Recent changes in cervical cancer screening guidelines: U.S. women\u2019s willingness for HPV testing instead of Pap testing","volume":"130","author":"Thompson","year":"2020","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical Cancer screening tests and Cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"issue":"20","key":"10.1016\/j.ygyno.2021.08.023_bb0180","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.2019.4595","article-title":"Cervical cancer screening: more choices in 2019","volume":"321","author":"Sawaya","year":"2019","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ygyno.2021.08.023_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6614a1","article-title":"Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties - United States","volume":"66","author":"Henley","year":"2017","journal-title":"MMWR Surveill. Summ."},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.023_bb0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PHH.0b013e3181a117da","article-title":"Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States","volume":"15","author":"Doescher","year":"2009","journal-title":"J. Public Health Manag. Pract."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0195","doi-asserted-by":"crossref","first-page":"106014","DOI":"10.1016\/j.ypmed.2020.106014","article-title":"Geographic and sociodemographic differences in cervical cancer screening modalities","volume":"133","author":"Goding Sauer","year":"2020","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.023_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15585\/mmwr.mm7002a1","article-title":"Cancer screening test receipt - United States, 2018","volume":"70","author":"Sabatino","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ygyno.2021.08.023_bb0205","series-title":"StatPearls. Treasure Island (FL)","article-title":"Atypical squamous cells of undetermined significance","author":"Ndifon","year":"2021"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:51Z","timestamp":1758772671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0090825821013214"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013\u20132019","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}